NNNaoto Nakagawa

Naoto Nakagawa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Naoto Nakagawa has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Evaluating generic skills through the PROG test in Japanese pharmacy education: A pilot study

    by Hiroshi Ohara, Keita Odanaka, Toshinori Ito, Shigeki Kisara, Kitae Ito, Naoto Nakagawa


  • Open Access

    Comparison of teaching methods: Formative assessment in traditional didactic lectures and learning monitoring system-based lectures

    by Naoto Nakagawa

    Background: Studies comparing formative assessment in traditional lecture settings and those incorporating Information and Communication Technology (ICT) tools are available, although direct head-to-head comparisons are less common. Objective: This study evaluated the effectiveness of formative assessment (FA) incorporating a learning monitoring system (LMS) as ICT in teaching methods, specifically in flipped classrooms, flipped classrooms and spaced learning, and traditional formative assessment (FA/TDL) to improve student learning outcomes. Methods: Pharmacy students in a drug-information course were divided into three groups: traditional formative assessment (FA/TDL; 68 students), flipped classroom (FA/FC/LMS; 74 students), and flipped classroom with spaced learning (FA/(FC+SL)/LMS; 74 students). The primary outcome measured was the mean difference in external mock test scores adjusted by grade-point averages (GPAs). Secondary outcomes identified factors influencing these score differences. Results: The results demonstrated that the learning method significantly impacted learning outcomes, with LMS improving learning outcomes compared to FA/TDL. Factors affecting test scores included sex, GPA, and the teaching methods used in the FA/FC/LMS and FA/(FC+SL)/LMS groups. Conclusion: This study suggests that implementing LMS in higher education can enhance student performance and support successful graduation.


  • A Pharmacoeconomic Study of Post-Exposure Prophylaxis Strategies for Influenza Virus Infections in Japan

    by Naoto Nakagawa, Runa Ono, Keita Odanaka, Hiroshi Ohara, Shigeki Kisara, Kitae Ito

    Introduction Vaccines can prevent influenza (flu) infections and are cost-effective for society and healthcare. However, the cost-effectiveness of post-exposure prophylaxis as a follow-up strategy is unclear. This study aims to evaluate the cost utility of post-exposure prophylaxis and treatment strategies with neuraminidase inhibitors and a cap-dependent endonuclease inhibitor for flu infections from the perspective of healthcare costs in Japan. Methods A base-case analysis was used to compare oseltamivir, zanamivir, and laninamivir for neuraminidase inhibitors and baloxavir marboxil for the endonuclease inhibitor. The costs of the first visit to a physician and pharmacy were excluded because of the policy on out-of-pocket expenses for post-exposure prophylaxis in Japan. Direct medical costs include the second physician visit, pharmacy and hospital admission expenses, and drug prices, based on the 2020 Japanese Medical Fee Index. The EuroQol-5Dimention-5Level was utilized to measure healthy participants’ quality of life scores, with a time horizon of 14 days. Deterministic and probabilistic sensitivity analyses were conducted. Results We have found baloxavir marboxil as the post-exposure prophylaxis agent and laninamivir as the treatment agent to be the most cost-effective strategy in Japan, followed by oseltamivir as the post-exposure prophylaxis agent and zanamivir as the treatment agent. Conclusions Baloxavir marboxil and oseltamivir are cost-effective prophylactic agents for flu from the perspective of healthcare costs in Japan. This strategy to select baloxavir marboxil or oseltamivir would be helpful to manage a formulary for post-exposure prophylaxis in Japan.


  • A Pilot Study on the Drug Price Revision Strategy in Japan: A Comparison Among Fiscal Years 2018, 2020, and 2022

    by Naoto Nakagawa, Mizuha Konno, Masami Kashiwabara, Shinya Shimoji, Jun Mochimaru, Tadao Inoue, Leanne Lai

    Objective: Japan has resumed its health technology assessment to decide how to reduce high-cost drug prices. While drug price rules in Japan are comprehensive, they do not necessarily capture differences in product characteristics. This study examined the drug price revision strategy in Japan using migraine treatment with triptans as an example. Cost data from fiscal years (FY) 2018, 2020, and 2022 were utilized. Methods: A cost-utility analysis was conducted from the perspective of healthcare payers, focusing on Japanese patients aged over 18 years experiencing migraines. The study employed a base-case model with probabilities derived from a network meta-analysis. Direct costs included medical and drug costs. Effectiveness was assessed using the European Quality of Life 5-dimensions—3-level questionnaire. Deterministic and probabilistic sensitivity analyses were conducted to examine the level of uncertainty. Results: In FY2018, sumatriptan and eletriptan were cost-effective; however, the other triptans were dominated by sumatriptan. In FY2020, sumatriptan and eletriptan were cost-effective, and rizatriptan was extended-dominated; nevertheless, the other triptans were dominated by sumatriptan. In FY2022, naratriptan and eletriptan were cost-effective; however, the other triptans were dominated by naratriptan. The hierarchy of triptan strategies varied in each fiscal year. Conclusions: This study provides valuable insights into the drug price revision strategy in Japan. The variations could be problematic because in Japan, formulary management of triptans, for example, those for migraine, may face revaluation every other year. Discussions regarding this issue will be further explored in the future.


  • Pharmacoeconomic study of anti-influenza virus drugs in Japan based on a network meta-analysis

    by Naoto Nakagawa, Yukinori Kanazawa, Akimasa Morikawa, Leanne Lai

    Background: An analysis was conducted in Japan to determine the most cost-effective neuraminidase inhibitor for the treatment of influenza virus infections from the healthcare payer’s standpoint. Objective: This study reanalysed the findings of a previous study that had some limitations (no probabilistic sensitivity analysis and quality of life scores measured by the EQ-5D-3L instead of the EQ-5D-5L) and used a decision tree model with only three health conditions. Methods: This study incorporated new data from a network meta-analysis study into the first examination. The second examination involved constructing a new decision tree model encompassing seven health conditions and identifying costs, which consisted of medical costs and drug prices based on the 2020 version of the Japanese medical fee index. Effectiveness outcomes were measured using EQ-5D-5L questionnaires for adult patients with a history of influenza virus infections within a 14-day time horizon. Deterministic and probabilistic sensitivity analyses were performed to examine the uncertainty. Results: In the first examination, the base-case cost-effectiveness analysis confirmed that oseltamivir outperformed laninamivir, zanamivir and peramivir, making it the most cost-effective neuraminidase inhibitor. The second examination revealed that oseltamivir dominated the other agents. Both deterministic and probabilistic sensitivity analyses showed robust results that validated oseltamivir as the most cost effective among the four neuraminidase inhibitors. Conclusions: This study thus reaffirms oseltamivir’s position as the most cost-effective neuraminidase inhibitor for the treatment of influenza virus infections in Japan from the perspective of healthcare payment. These findings can help decision makers and healthcare providers in Japan.


  • Cost-effectiveness Analysis of Second-Generation Antihistamine 1 Receptor Blockers and Japanese Kampo Shoseiryuto for Treating Perennial Allergic Rhinitis in Outpatient Settings in Japan

    by Naoto Nakagawa, Masami Kashiwabara, Kei Egawa, Ayaka Sasaki

    Objectives: Perennial allergic rhinitis (PAR) is common in Japan. Second-generation antihistamines (SGAs) are commonly used for its treatment; however, it remains unclear which SGA is the most cost-effective. Additionally, the pharmacoeconomics of Japanese Kampo shoseiryuto (which was traditionally prescribed to treat PAR in Japan) remains poorly understood. In this study, we aimed to investigate the effectiveness of various SGAs and shoseiryuto for the treatment of PAR in Japanese outpatients, from the healthcare payer’s perspective. Methods: The most cost- and clinically effective SGAs were determined from a list of 6 SGAs (bepotastine, 10 mg; cetirizine, 10 mg; ebastine, 10 mg; epinastine, 20 mg; loratadine, 10 mg; and olopatadine, 5 mg) together with shoseiryuto, using the overall improvement rate through a model-based analysis. The time horizon was 28 days. Costs were determined based on the Medical Fee Index in 2020. Deterministic and probabilistic sensitivity analyses were conducted to address the uncertainty of the base-case results. Results: Overall, bepotastine (10 mg) and ebastine (10 mg) were cost-effective. Shoseiryuto was less cost-effective than ebastine (10 mg) (dominated). Ebastine (10 mg) was the most cost-effective option based on deterministic and probabilistic sensitivity analyses. Conclusions: Ebastine (10 mg) was the most cost-effective treatment strategy for PAR among the agents evaluated in this study. This insight could aid in establishing an appropriate formulary for treating PAR in hospitals and communities.


  • Cost-effectiveness analysis of anti-influenza drugs in adult outpatient settings in Japan

    by Naoto Nakagawa, Satoru Harada, Kiyohito Morita, Akimasa Morikawa, Yukinori Kanazawa, Leanne Lai


    • 15 June 2021
      • Vol. 25  (3) , 258-262

    Study on the Optimal Conditions for Long-term Storage of Melatonin Powder as an In-hospital Preparation.

    by Keita Odanaka, Hiroki Kojima, Naoto Nakagawa

    Melatonin is often prescribed to children with epilepsy. It is supplied as an in-hospital preparation in Japan, but information on the storage conditions of such formulations is lacking. In this study, we used an analytical method to perform periodic measurements in order to establish expiration periods and storage conditions for compounded melatonin powder. A dispenser was used to envelop compounded melatonin powder in wrapping paper, after which the powders were preserved in 1) an opened transparent plastic bag, 2) a closed opaque plastic bag, 3) a closed transparent plastic bag with a desiccant, and 4) a closed opaque plastic bag with a desiccant. The bags were then stored at room temperature (15°C to 25°C), in a refrigerator (4°C), and in a freezer (-20°C). Chromatographic analysis was performed using an ODS-C18 column (40°C, ? = 210 nm) with a mobile phase consisting of methanol: 0.1 M sodium phosphate buffer (55:45, v/v) at a flow rate of 1 mL/min. The measurements were made at the following time points: 0 days, 7 days, 14 days, 28 days (1 month), 56 days (2 months), 84 days (3 months), 112 days (4 months), 140 days (5 months), and 168 days (6 months). The residual rates of melatonin for all time points, at all temperatures, under all conditions exceeded 95%. These experimental data suggested that the melatonin powder is stable for at least 6 months at room temperature of 15°C to 25°C.

  • Open Access

    Comparative study between formative assessment and flipped classroom lectures in a drug information course ‎

    by Naoto Nakagawa

    To compare the short- and long-term retention of knowledge between formative assessment (FA) and flipped classroom (FC) lectures in a drug information course for pharmacy students in Japan. FA lectures were conducted as traditional in-person lectures, and a paper-based reflection quiz was administered at the end of each lecture for approximately ten minutes as a formative assessment. In contrast, FC lectures required students to watch videos before attending lectures, and a multiple-choice test